This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Connolly, D C Articles by Maihle, N J Search for Related Content PubMed PubMed Citation Articles by Connolly, D C Articles by Maihle, N J

 Previous Article  |  Next Article 

J Virol. 1994 October; 68(10): 6804-6810

Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.

D C Connolly, S L Toutenhoofd and N J Maihle

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905.

ABSTRACT

Expression of mutant avian c-erbB1 genes results in tissue-specific transformation in chickens. Site-directed mutagenesis was used to generate kinase-defective mutants of several tissue-specific v-erbB transforming mutants by replacement of the ATP-binding lysine residue in the kinase domain with an arginine residue. These kinase-defective v-erbB mutants were analyzed for their in vitro and in vivo transforming potentials. Specifically, kinase-defective mutants of erythroleukemogenic, hemangioma-inducing, and sarcomagenic v-erbB genes were assessed for their oncogenic potential. In vitro transformation potential was assessed by soft-agar colony formation in primary cultures of chick embryo fibroblasts (CEF). In vivo transformation potential was determined by infection of 1-day-old line 0 chicks with concentrated recombinant retrovirus and then monitoring of birds for tumor formation. These transformation assays demonstrate that kinase activity is absolutely essential for transformation by tissue-specific transforming mutants of the avian c-erbB1 gene. Since all of the tissue-specific v-erbB mutants characterized to date exhibit tyrosine kinase activity in vitro but do not transform all tissues in which they are expressed, we conclude that v-erbB-associated tyrosine kinase activity may be necessary but is not sufficient to induce tumor formation.

---

J Virol. 1994 October; 68(10): 6804-6810

This article has been cited by other articles:

• Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Hua, X., Harris, S. S., Vanderhyden, B. C., Hamilton, T. C. (2003). Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer. Cancer Res. 63: 1389-1397 [Abstract] [Full Text]  
• Boerner, J., McManus, M., Martin, G., Maihle, N. (2000). Ras-independent oncogenic transformation by an EGF-receptor mutant. J. Cell Sci. 113: 935-942 [Abstract]  
• Wang, Z., Danielsen, A. J., Maihle, N. J., McManus, M. J. (1999). Tyrosine Phosphorylation of Caldesmon Is Required for Binding to the Shc{middle dot}Grb2 Complex. J. Biol. Chem. 274: 33807-33813 [Abstract] [Full Text]  
• McManus, M. J., Lingle, W. L., Salisbury, J. L., Maihle, N. J. (1997). A transformation-associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-ErbB signaling to actin stress fiber disassembly. Proc. Natl. Acad. Sci. USA 94: 11351-11356 [Abstract] [Full Text]  
• Boerner, J. L., Danielsen, A., McManus, M. J., Maihle, N. J. (2001). Activation of Rho Is Required for Ligand-independent Oncogenic Signaling by a Mutant Epidermal Growth Factor Receptor. J. Biol. Chem. 276: 3691-3695 [Abstract] [Full Text]